📰 Eric Baudin News
Eric Baudin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Baudin. Real-time updates on events, politics, business and more.
October 16, 2023
Oral Presentation at ESMO will feature updated results from Phase 1/2 SPENCER studyPARIS, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liquid malignancies and inflammatory diseases based on its unique Mimicry platform, today announced that updated data from its Phase 1/2 SPENCER study on EO2401, in combination with nivolumab in patients with adrenal tumors, will be presented in an oral session at the European
October 12, 2023
First presentation of results from CheckMate -901 show survival benefit with Opdivo + chemotherapy in the first-line treatment of patients with unresectable or metastatic urothelial carcinoma who...
September 22, 2022
177Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
September 20, 2022
177Lutetium-octreotate can improve progression-free survival vs sunitinib in patients with progressive pancreatic neuroendocrine tumors.
September 6, 2022
Enterome is evaluating EO2401 in Phase 1/2 clinical trials in recurrent glioblastoma (ROSALIE) and adrenocortical malignancies (SPENCER) Proof-of-concept data...
September 6, 2022
Enterome is evaluating EO2401 in Phase 1/2 clinical trials in recurrent glioblastoma (ROSALIE) and adrenocortical malignancies (SPENCER)Proof-of-concept data in both trials of EO2401 have demonstrated
September 5, 2022
05.09.2022 - Bristol Myers Squibb (NYSE: BMY) today announced the presentation of scientific research across several solid tumors showcasing the breadth of the Company’s oncology development program at the European Society for Medical Oncology (ESMO) Congress ...
November 2, 2021
AN INTERNATIONAL COLLECTIVE of oncology clinicians and researchers came together to share the most recent updates in patient care and...
December 16, 2020
Bureau Veritas awards PONANT with notation to manage underwater radiated noise Le Jacques-Cartier, the last sister-ship in the PONANT EXPLORERS series of six expedition class cruise ships, has been awarded the Bureau Veritas class notation NR614 for Underwater Radiated Noise (URN). The award of the notation reflects PONANT’s commitment to reducing the environmental impact of its ships and operations. NR614 establishes requirements for the measurement of underwater radiated noise and the ‘ac...